TherapeuticsMD Inc (TXMD)
1.90
-0.02
(-1.04%)
USD |
NASDAQ |
Apr 25, 10:49
TherapeuticsMD Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -1.939 |
| June 30, 2022 | -3.483 |
| March 31, 2022 | -1.443 |
| December 31, 2021 | -2.011 |
| September 30, 2021 | -3.256 |
| June 30, 2021 | -3.775 |
| March 31, 2021 | -19.41 |
| December 31, 2020 | -1.917 |
| September 30, 2020 | -2.043 |
| June 30, 2020 | -2.591 |
| March 31, 2020 | -5.384 |
| December 31, 2019 | 21.15 |
| September 30, 2019 | -9.156 |
| June 30, 2019 | 23.98 |
| March 31, 2019 | 1.211 |
| December 31, 2018 | 0.7524 |
| September 30, 2018 | 0.5458 |
| June 30, 2018 | 0.9432 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.0025 |
| December 31, 2012 | -2.504 |
| September 30, 2012 | -1.290 |
| June 30, 2012 | -5.030 |
| March 31, 2012 | -1.062 |
| December 31, 2011 | -1.373 |
| September 30, 2011 | -0.8494 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-19.41
Minimum
Mar 2021
23.98
Maximum
Jun 2019
-0.5934
Average
-1.939
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 43.31M |
| Total Liabilities (Quarterly) | 14.02M |
| Shareholders Equity (Quarterly) | 29.29M |
| Current Ratio | 1.721 |
| Net Debt Paydown Yield | 72.15% |